410.1 Performance of cystatin-based formulas to estimate glomerular filtration rate in pediatric kidney transplant recipients.
Dr. Elodie Cheyssac, France
410.2 Design and protocol of an international multicentre study on molecular profiling of allograft rejection in paediatric kidney transplant patients: the PANDA-Kids-ATLAS study.
Dr. Evgenia Preka, France
410.3 Rate of eGFR improvement early post-transplant and long-term graft outcome in pediatric renal transplantation
Dr. Chen Rosenberg Danziger, Israel
410.4 Optimizing Post-Transplant Growth in Pediatric Kidney Recipients: A Dual Approach Integrating SNP-Based Machine Learning Prediction and Early Glucocorticoid Withdrawal Strategies
Miss Yi Feng, People's Republic of China
410.5 Identifying high-risk hearts after pediatric kidney transplantation: linking diastolic dysfunction to myocardial fibrosis
Mr. Tim A. Ubenauf, Germany
410.6 Impact of HLA-DQα05 Heterodimer Mismatch on De Novo Donor-Specific Antibody Formation in Pediatric Kidney Transplantation
Dr. Vaka K Sigurjonsdottir, United States
410.7 Thrombotic and Hemorrhagic Events After Pediatric Kidney Transplantation: A Single-Center Assessment of Anticoagulation Protocol
Prof. Julien Hogan, France
410.8 Risk factors for loss of varicella immunity after pediatric kidney transplantation
Helen Pizzo, United States
410.9 Continuous long term exposure to lower blood pressure stabilizes kidney graft function and improves graft survival in children